Tagged: CBD Toggle Comment Threads | Keyboard Shortcuts

  • ShereeKrider 5:24 pm on December 19, 2016 Permalink | Reply
    Tags: CBD, ,   

    Ananda Hemp Comments on Recent DEA Ruling 


    News provided by

    Ananda Hemp

    Dec 19, 2016, 11:26 ET

     

    LEXINGTON, Ky., Dec. 19, 2016 /PRNewswire/ — Last Wednesday, December 14th, the Drug Enforcement Administration (DEA) issued a ruling on the coding of “marihuana extracts.” Many questions have arisen in the marketplace from those concerned that the intention of the agency was to seemingly classify hemp-derived extracts containing Cannabidiol (CBD) Schedule I substances.

    Ananda Hemp and our parent company Ecofibre have sought legal advice and believe the Final Rule published by DEA doesnot change the legal status of CBD as this can only be done by a scheduling action which has NOT occurred. We are within the belief that the ruling was a mere administrative action and not an attempt to bypass any Congressionally imposed laws such as the 2014 Farm Bill, or any other necessary judicial process.

    We strongly believe that our farming operations and products obtained under those operations are, and will continue to be, compliant and legal in all 50 states:

    • Cannabidiol (CBD) is not listed on the federal schedule of controlled substances;
    • Sec. 7606 of the Farm Bill defines hemp as distinct from marijuana and is therefore removed from the definition as a controlled substance when grown under a compliant state program;
    • The 2015 Congressional Appropriations act and corresponding 2016 Appropriations Act specifically defunded the DEA and other governmental agencies from interfering with the processing, use, or sale of industrial hemp that was cultivated in compliance with section 7606 of the 2014 Farm Bill;
    • The code assigned to “marihuana extract” in the rule is “Administration Controlled Substances Code Number” for the purposes of identification of substances on registration forms;
    • Therefore, the Final Rule published on December 14th was not a scheduling action but rather an administrative action related to record keeping

    Ecofibre has been working in the state of Kentucky since 2014 and operated under the full extent of section 7606 of the 2014 Farm Bill. To date the company has invested millions of dollars in the region and created a broad range of jobs and farming salaries in Central Kentucky. This year we contracted 500 acres of industrial hemp production and have recently completed yet another successful harvest season. Our brand, Ananda Hemp, has recently entered the marketplace in good favor with consumers and channel partners as we now endeavor to enter into the market research phase of our 5-year pilot program.

    Our company will continue to scale our operations in Kentucky and the USA alike by continuing to contract industrial hemp production with American farmers and bringing quality, domestically-produced products to market for sale in all 50 states.

    About Ecofibre

    Ecofibre is an Australian company that maintains one the world’s largest and most diverse seed banks of cannabis sativa germplasm, which includes several certified industrial hemp cultivars.

    Ecofibre has strong research partnerships with several leading Universities and currently utilizes its licenses to grow industrial hemp for the purposes of research and production.

    Ecofibre is privately funded by some of Australia’s leading business leaders as well as Joy and Barry Lambert, the most noted cannabis philanthropists in the industry.

    Contact
    Eric Wang
    +61 (0)403 570 377 
    eric.wang@ecofibre.com.au

    About Ananda Hemp

    Ananda Hemp is a premier provider of health and wellness products that are exclusively derived from industrial hemp cultivated compliantly in Kentucky, USA under the accordance of section 7606 of the 2014 Farm Bill.

    Contact
    John Ryan
    +1 858 405 8615
    john@anandahemp.com

    SOURCE Ananda Hemp

     
  • ShereeKrider 7:28 pm on December 18, 2016 Permalink | Reply
    Tags: authority, , CBD, , Marketwired,   

    DEA Hurts Growing Industry and Exceeds its Authority Regarding Scheduling Controlled Substances; Enacts Final Rule Seeking to Make Any Extract of the Cannabis Plant a Schedule 1 Drug 


    Hoban Law Group

    December 14, 2016 19:29 ET

    DEA Hurts Growing Industry and Exceeds its Authority Regarding Scheduling Controlled Substances; Enacts Final Rule Seeking to Make Any Extract of the Cannabis Plant a Schedule 1 Drug

    DENVER, CO–(Marketwired – December 14, 2016) – On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially devastate developing businesses and consumer, textile and manufacturing industries related to cannabinoids. Robert Hoban, a cannabis, cannabinoid and hemp lawyer and expert as well as an adjunct professor of law at The University of Denver, states the DOJ and DEA cannot unilaterally make law and schedule controlled substances, thus causing this Final Rule to exceed the DEA’s authority. Instead, such actions require an act of Congress.

    As is the case here, the DEA is an agency that has previously sought to exceed its authority contrary to applicable law. It is anticipated that this “final ruling” and determination will be challenged both in court and administratively across the country. With 28 states that already have medical cannabis laws on the books, 8 states passing adult use laws in the November election, and numerous other states enacting industrial hemp legislation, the industry is up for the challenge of litigation against any government agency that operates contrary to prevailing law and enforcement policies.

    The DEA’s Final Rule seeks to broadly expand and override existing definitions of controlled substances by newly creating a “Marihuana Extract” classification. The effect of this Final Rule appears to be incorporation of any and all cannabinoids from the Cannabis plant as a Schedule 1 controlled substance, despite the fact that many such cannabinoids are naturally occurring derived from non-“marihuana” portions of the plant or or from entirely different plants altogether. Problematically, the Final Rule fails to acknowledge there exist certain parts of the plant, and certain types of the plant — namely, industrial hemp — which cannot and should not be treated as a “Marihuana Extract.” Notably, the DEA has sought to unilaterally create laws before, and has lost, when challenged.

    Hoban surmises, “The feeling is that this is an action beyond the DEA’s authority and we believe this is unlawful and we are taking a course of action for our clients. This Final Rule serves to threaten hundreds, if not thousands, of growing businesses, with massive economic and industry expansion opportunities, all of which conduct lawful business in reliance upon the Federal Government also acting pursuant to law, and as ordered by the Ninth Circuit in 2003 and 2004. We will see the Federal Government in court.”

    Image Available: http://www.marketwire.com/library/MwGo/2016/12/14/11G125277/Images/Hoban_Photo-82fa3561cc6d93ea991b06d3c4c27235.jpg

    Contact Information

     
c
Compose new post
j
Next post/Next comment
k
Previous post/Previous comment
r
Reply
e
Edit
o
Show/Hide comments
t
Go to top
l
Go to login
h
Show/Hide help
shift + esc
Cancel
%d bloggers like this: